Summary
Zidovudine (formerly azidothymidine) is a potent inhibitor of the human immunodeficiency virus (HIV) reverse transcriptase and represents the first approved drug showing clinical efficacy in HIV-associated diseases. However, considerable toxicity causing macrocytic anemia, neutropenia, and myopathy has been reported, with severe mitochondrial alterations as a special feature of this myopathy. The mitochondrial changes are consistent with the fact that zidovudine acts as an inhibitor of the mitochondrial gamma-polymerase. Electron microscopically, we could confirm the presence of severely altered mitochondria in a 32-year-old male, who developed a necrotizing myopathy after daily administration of 1,000 mg zidovudine over a period of 15 months. In addition, there were even more severe nuclear changes that, for the most part, have not been documented electron microscopically in HIV-related myopathy either with or without zidovudine treatment, especially in non-necrotic and non-regenerating fibers. Since various in vitro studies have shown interference of zidovudine with nuclear DNA metabolism even in human cell lines, we assume that the nuclear changes that we observed are at least in part related to zidovudine treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Avramis VI, Markson W, Jackson RL, Gomperts E (1989) Biochemical pharmacology of zidovudine in human T-lymphoblastoid cell (CEM). AIDS 3:417–422
Balzarini J, Pauwels R, Baba M, Herdewijn P, De Clerko E, Broder S, Johns DG (1988) The in vitro and in vivo antiretro-virus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol 37:897–903
Banker BQ (1975) Dermatomyositis of childhood. Ultrastructural alterations of muscle and intramuscular blood vessels. J Neuropathol Exp Neurol 33:46–75
Barré-Sinoussi F, Chermann JC, Rey R, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Brun-Vézinet F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotrophic retrovirus from a patient at risk for aquired immune deficiency syndrome (AIDS). Science 220:868–871
Bessen LJ, Greene JB, Louie E, Seitzman P, Weinberg H (1988) Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N Engl J Med 318:708
Bhalla K, Birkhofer M, Grant S, Graham G (1989) The effect of recombinant human granulocyte-macrophage colonystimulating factor (rGM-CSF) in 3′-azido-3′-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. Exp Hematol 17:17–20
Bolden A, Noy GP, Weissbach A (1977) DNA polymerase of mitochondria is a gamma-polymerase. J Biol Chem 252:3352–3356
Byars N, Kidson C (1975) DNA chain termination by 2′,3′-dideoxythymidine in replicating mammalian cells. Biochemistry 14:3159–3164
Carpenter S, Karpati G (1984) Pathology of skeletal muscle. Churchill Livingstone, New York
Cheng Y-C, Dutschman GE, Bastow KF, Sarngadharan MG, Ting RYC (1987) Human immunodeficiency reverse transcriptase. J Biol Chem 262:2187–2189
Collen JP (1987) Dermatomyositis. Dis Mon 33:263–264
Dalakas MC, Pezeshkpour GH (1988) Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol 23 [Suppl]:S38-S48
Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by longterm zidovudine therapy. N Engl J Med 322:1098–1105
De Miranda P, Weller S, Maha M (1989) Pharmacokinetics of zidovudine (ZVD) and acyclovir (ACV) during concurrent administration in asymptomatic men with HIV-infection. The 4th International Conference on AIDS, Stockholm, Acta Pathol Microbiol Immunol Scand 97 [Suppl 8]: abstr no 3136
Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard PM, Perronne C, Salmon D, De Truchis P, Leport C, Bouvet E, Pazza MC, Levacher M, Regnier B (1988) Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet II:1297–1302
Emura M (1978) Morphological studies on the development of tracheal epithelium in the Syrian golden hamster. IV. Electron microscopy: Blebbing of nuclear membrane. Z Versuchstierkd 20:163
Fardeau M, Tomé FMS (1981) Non-neoplastic disorders of skeletal muscle. In: Johannessen (ed) Electron microscopy in human medicine, vol 4. McGraw-Hill, New York, pp 257–319
Fiddian AP (1988) Zidovudine plus or minus acyclovir in patients with AIDS or ARC. The 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, abstr no 348
Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Scooley RT, Jackson GG, Durack DT, King D (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double blind, placebo-controlled trial. N Engl J Med 317:185–191
Fischl MA, Richman DD, Causey DM, Grieco MH, Bryson Y, Mildvan D, Laskin OL, Groopman JE, Volberding PA, Scooley RT, Jackson GG, Durack DT, Andrews JC, Nusinoff-Lehrmans, Barry DW (1989) Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 262:2405–2410
Fukuyama K, Epstein WL (1971) Inhibition of RNA and protein synthesis in granular cells by actinomycin-D and puromycin. J Invest Dermatol 56:211–222
Furman PA, Fyfe JA, St. Clair MA, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H, Barry DW (1986) Phosphorylation of 3′ azido-3′deoxythymidine and selective interaction with human immunodeficiency reverse transcriptase. Proc Natl Acad Sci USA 83:8333–8337
Gabbai AA, Schmidt B, Castelo A, Oliveira ASB, Lima JGC (1990) Muscle biopsy in AIDS and ARC: analysis of 50 patients. Muscle Nerve 13:541–544
Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TL, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PD (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500–503
Gamboa ET, Eastwood AB, Hays Ap, Maxwell J, Penn AS (1979) Isolation of influenza virus from muscle in myoglobinuric polymyositis. Neurology 29:1323–1335
Gertner E, Thurn JR, Williams DN, Simpson M, Belfour HH, Rhame F, Henry K (1988) Zidovudine-associated myopathy. Am J Med 86:814–818
Ghadially FN (1988) Ultrastructural pathology of the cell and matrix, vol 1, 3rd edn. Butterworths, London, pp 1–158
Gorard DA, Henry K, Giloff RJ (1988) Necrotizing myopathy and zidovudine. Lancet I:1050
Halger DN, Frame PT (1986) Azidothymidine neurotoxicity (letter). Lancet II:1392–1393
Hantai D, Fournier J-G, Vazeux R, Collin H, Baudrimont M, Fardeau M (1991) Sceletal muscle involvement in human immunodeficiency virus infection. Acta Neuropathol 81:496–502
Helbert M, Fletcher T, Peddle B, Harris JRW, Pinching AJ (1988) Zidovudine-associated myopathy. Lancet II:689–690
Hodak E, Gadoth N, David M (1986) Muscle damage induced by isoretinoin. Br Med J 293:425–426
Huang P, Farquhar D, Plunkett W (1990) Selective action of 3′-azido-3′deoxythymidine 5′-triphosphate on viral reverse transcriptases and human DNA-polymerases. J Biol Chem 265:11914–11918
Jézéquel AM, Shreeve MM, Steiner JW (1967) Segregation of nucleolar components in mycoplasma-infected cells. Lab Invest 16:287–304
Kurth R (1988) Das erworbene Immunmangelsyndrom AIDS. In: Brandis H, Pulverer G (eds) Medizinische Mikrobiologie, 6th edn. Gustav Fischer Verlag. Stuttgart, pp 723–732
Lange DJ, Rubin M, Britton CB, Hays AP, Yuonger DS (1990) Disorders of peripheral nerves associated with HIV infection. Clin Podiatr Med Surg 7:71–81
MacDonell, Murphy R, Sahgal V, Skoutelis A, Phair JP (1989) Myopathy associated with HIV infection and zidovudine therapy. CDC AIDS Weekly 16:23
Mastaglia FL (1980) Drug-induced disorders of muscle. Br J Hosp Med 23:8–16
Matthes E, Lehman C, Scholz D, v.Janta-Lipinski M, Gaertner K, Rosenthal HA, Langen P (1987) Inhibition of HIV associated reverse transcriptase by sugar-modified derivatives of thymidine 5′-triphosphate in comparison to cellular polymerases alpha and beta. Biochem Biophys Res Commun 148:78–85
Melamed AJ, Muller RJ, Gold JWM, Wise Campbell S, Kleinberg ML, Armstrong D (1987) Possible zidovudine-induced hepatoxicity (letter). JAMA 258:2063
Mhiri C, Baudriment M, Bonne G, Geny Degoul F, Marsac C, Roullet E, Gherardi R (1991) Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 29:606–614
Munch-Petersen B (1988) Azidothymidine inhibits mitogenstimulated growth and DNA repair in human peripheral lymphocytes. Biochem Biophys Res Commun 157:1369–1375
Nordstrom DM, Petropolis AA, Giorno R, Gates RH, Reddy VB (1989) Inflammatory myopathy and aquired immune deficiency syndrome. Arthritis Rheum 32:475–479
Panegyres PK, Tan N, Kakulas BA, Armstrong JA (1988) Necrotizing myopathy and zidovudine. Lancet I:1050–1051
Panegyres PK, Papadimitriou JM, Hollingsworth PN, Armstrong JA, Kakulas BA (1990) Vesicular changes in the myopathies of AIDS. Ultrastructurral observations and their relationship to zidovudine treatment. J Neurol Neurosurg Psachiatry 53:649–655
Parker WB, White EL, Shaddix SC, Ross LJ, Buckheit RW, Germany JM, Secrist JA, Vince R, Shannon WM (1991) Mechanism of inhibition of human immunodeficiency virus type I reverse transcriptase and human DNA-polymerases alpha, beta and gamma by the 5′triphosphates of carbovir, 3′-azido-3′-deoxythymidine, 2′,3′-dideoxyguanosine, and 3′-deoxythymidine. J Biol Chem 266:1754–1762
Popovic M, Sarnpadharan MG, Read E, Gallo RC (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
Reddy J, Svoboda D (1968) The relationship of nucleolar segregation to ribonucleic acid synthesis following the administration of selected hepatocarcinogens. Lab Invest 19:132–145
Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, Jackson GG, Durack DT, Nusinoff-Lehrman S (1987) The toxicity of azidothymidine (AZT) in treatment of patients with AIDS and AIDS-related complex: a double blind, placebo-controlled trial. N Engl J Med 317:192–197
Scanlon KJ, Kashani-Sabet M, Sowers LC (1989) Overexpression of DNA replication and repair enzymes in cisplatinresistant human colon carcinoma HCT8 cells and circumvention by azidothymidine. Cancer Commun 1:269–275
Schröder JM (1982) Pathologie der Muskulatur. In: Doerr J, Seifert G, Uehlinger E (eds) Spezielle pathologische Anatomie, vol 15. Springer, Berlin Heidelberg New York p 301
Schröder JM, Krämer KG, Hopf HC (1985) Granular nuclear inclusion body disease: fine structure of tibial muscle and sural nerve. Muscle Nerve 8:52–59
Scovassi AI, Wicker R, Bertazzoni U (1979) A phylogenetic study on vertebrate mitochondrial DNA polymerase. Eur J Biochem 100:491–496
Simpson MV, Chin CD, Keilbaugh SA, Lin T-S, Prusoff WH (1989) Studies on the inhibition of mitochondrial DNA-replication by 3′-azido-3′-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication. Biochem Pharmacol 38:1033–1036
Sistori C, Bosisio M (1966) Oncolysis by herpes simplex. Lancet I:96
Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Posner JB (1983) Neurological complications of aquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol 14:403–418
Sommadossi J-P, Carlisle R (1987) Toxicity of 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-3-propoxymethyl) guanine for normal human hematopoietic progenitor cells in vitro. Antimicrob Agents Chemother 31:452–454
Sommadossi J-P, Carlisle R, Zhou Z (1989) Cellular pharmacology of 3′-azido-3′-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. Mol Pharmacol 36:9–14
St. Clair MH, Richards CA, Spector T, Weinhold KJ, Miller WH, Langlois AJ, Furman PA (1987) 3′-Azido-3′-deoxythymidine triphosphate and an inhibitor and substrate of purified human immunodeficiency virus revese transcriptase. Antimicrob Agents Chemother 31:1972–1977
Stern R, Gold J, DiCarlo EF (1987) Myopathy complicating the aquired immune deficiency syndrome. Muscle Nerve 10:318–322
Swanson JL, Craighead JE, Reynolds ES (1966) Electron microscopic observations of herpes virus hominis (herpes simplex virus) encephalitis in man. Lab Invest 15:1966–1981
Takahashi K, Ogita T, Okudaira H (1986) d-Penicillamine-induced polymyositis in patients with rheumatoid arthritis. Arthritis Rheum 29:560–564
Tomé FMS, Fardeau M (1986) Nuclear changes in muscle disorders. Meth Achiev Exp Pathol 12:261–296
Tyrsted G (1984) Effect of 5-fluoro-2′-deoxyuridine and hydroxyurea on the phythemagglutinin-induced increase of thymidine kinase, replicative DNA polymerase, deoxycytidylate deaminase, and CDP reductase activity in human lymphocytes. Mol Cell Biochem 62:165–174
Watson AJS, Dalbow MH, Stachura I (1983) Immunologic studies in cimetidine-induced nephropathy and polymyositis. N Engl J Med 308:142–145
Wier KA, Fukuyama K, Epstein WL (1971) Nuclear changes during keratinization of normal human epidermis. J Ultrastruct Res 37:138–145
Weidner DA, Sommadossi J-P (1990) 3′-azido-3′-deoxythymidine inhibits globin gene transcription in butyric acidinduced K-962 human leukemia cells. Mol Pharmacol 38:797–804
Weiss M, Meyer J (1972) Comparison of the effects of Coxsackie virus A9 and of actinomycin D on the nucleolar ultrastructure of the monkey kidney cells. J Ultrastruct Res 38:411–419
Wiley CA (1989) Neuromuscular diseases of AIDS. FASEB J 3:2503–2511
Wiley CA, Nerenberg M, Cros D, Soto-Aguilar MC (1989) HTLV-I myositis in a patient also infected with the human immunodeficiency virus. N Engl J Med 320:992–995
Wischnitzer S (1974) The nuclear envelope: its ultrastructure and functional significance. Endeavour 33:137–142
Wrzolek MH, Sher JA, Kozlowski PB, Rao C (1990) Skeletal muscle pathology in AIDS: an autopsy study. Muscle Nerve 13:508–515
Yarchoan R, Klecker RW, Weinhold KJ, Markham PD, Lyerly HK, Durack DT, Gelmann E, Nusinoff Lehrmann S, Blum RM, Barry DW, Shearer GM, Fischl MA, Mitsuya H, Gallo RC, Collins JM, Bolognesi DP, Myers CE, Broder S (1986) Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet I:575–580
Yoshida Y, Yoshida C (1990) Reversal of azidothymidine-induced bone-marrow suppression by 2′,3′-dideoxythymidine as studied by hematopoietic clonal culture. AIDS Res Hum Retroviruses 6:929–932
Zhu Z, Carlisle R, Sommadossi J-P (1988) Studies on mechanism of toxicity of 3′-azido-3′-deoxythymidine (AZT) in human bone marrow (HBM) cells. Intersci Conf Antimicrob Agents Chemother 28:1466
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schröder, J.M., Bertram, M., Schnabel, R. et al. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine. Acta Neuropathol 85, 39–47 (1992). https://doi.org/10.1007/BF00304632
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00304632